Next Generation News and Research

RSS

Claret receives CE Mark for Sentinel CPS for embolic protection during aortic valve replacement

Claret Medical, Inc., a developer of innovative solutions for cerebral protection during structural heart interventions, vascular interventions, and cardiac surgery procedures, announced that it has received CE Mark for the Sentinel Cerebral Protection System for embolic protection during Transcatheter Aortic Valve Replacement.

28 Jan 2014

New halal testing method for detecting pig and horse contamination of meat

The mislabeling of meat products sold for human consumption has serious implications from a safety and ethical perspective. With recent news stories of pork and horsemeat contamination in different parts of the world, a renewed need for specialized testing of the food supply has rapidly arisen.

28 Jan 2014

GenePeeks receives patent for developing innovative algorithms to create hypothetical "digital babies"

GenePeeks, Inc., a genetic technology company focused on pre-conception risk prediction, announced today it has been issued patent No. 8,620,594, titled "Method and System for Generating a Virtual Progeny Genome," by the United States Patent and Trademark Office.

28 Jan 2014

Myelin Repair Foundation enters into agreement with NIH to assess MRF-008 for multiple sclerosis

The Myelin Repair Foundation today announced it has entered a Cooperative Research and Development Agreement with the National Institutes of Health to assess MRF-008, as a potential therapeutic for multiple sclerosis. This CRADA will facilitate collaboration between the MRF and National Institute of Neurological Disorders and Stroke at the NIH Clinical Center to study MRF-008, a drug identified by the MRF as a potential neuroprotective therapeutic to enhance repair in multiple sclerosis patients.

27 Jan 2014

DKFZ, AstraZeneca EORTC join Worldwide Innovative Network Consortium

The Worldwide Innovative Network (WIN) Consortium in personalized cancer medicine is proud to announce that AstraZeneca, DKFZ and EORTC have joined the Consortium.

27 Jan 2014

UM professors receive grant to help athletes, military members suffering from traumatic brain injury

Athletes, members of the military and others suffering from traumatic brain injury may benefit from research conducted by two University of Montana faculty members through a new $300,000 grant awarded by General Electric Co. and the National Football League.

25 Jan 2014

Collaboration between NFL and GE seeks to improve safety of athletes, soldiers who sustain mild TBI

When the Broncos and the Seahawks meet on the gridiron for Superbowl XLVIII, player and team statistics - passer ratings, rushing yards, sacks and fumbles - will be tossed around like, well, a football.

24 Jan 2014

Researchers use advanced neuroimaging techniques to study how concussions affect blood flow in brain

Researchers at the Indiana University School of Medicine will use advanced neuroimaging techniques to study area high school athletes to learn how concussions affect blood flow in the brain.

24 Jan 2014

Next-generation high content screening system launched by PerkinElmer

PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, has announced the launch of the Opera Phenix™, a next-generation, confocal, high-content screening system that will enable scientists to perform the most challenging applications with greater speed and sensitivity, accelerating the understanding of disease and discovery of new and more effective treatments.

23 Jan 2014

Exposing adolescent to marijuana can lead to behavioral alterations in next generation

Exposing adolescent rats to THC (tetrahydrocannabinol) -the primary psychoactive ingredient in marijuana—can lead to molecular and behavioral alterations in the next generation of offspring, even though progeny were not directly exposed to the drug, researchers at the Icahn School of Medicine at Mount Sinai have found.

23 Jan 2014

NCCC physicians use new gene sequencing equipment for testing abnormal DNA in cancerous tumor cells

Clinical laboratory experts and physicians at Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC) achieved 100 percent accuracy in testing for abnormal DNA in cancerous tumor cells with its new gene sequencing equipment and panels.

23 Jan 2014

Scientists develop new genetic platform that yields novel antibiotic from ocean bacteria

Scientists at the University of California, San Diego have developed a new genetic platform that allows efficient production of naturally occurring molecules, and have used it to produce a novel antibiotic compound.

23 Jan 2014

Vivaldi Biosciences inks agreement with NIAID to evaluate LAIV candidates against influenza A

Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing live attenuated influenza vaccines against seasonal and pandemic influenza, today announced that it has signed a Cooperative Research and Development Agreement with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to generate and evaluate in preclinical studies LAIV candidates against influenza A(H7N9).

21 Jan 2014

Fluxion Biosciences announces release of IsoFlux Rare Cell Enrichment Kit

Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.

From Fluxion Biosciences 21 Jan 2014

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.

21 Jan 2014

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Advaxis, Inc., a leader in developing the next generation of cancer immunotherapies, announced that the first patient has been dosed in a Phase 1/2 "window of opportunity" study being conducted by the Icahn School of Medicine at Mount Sinai. Patients diagnosed with HPV-associated head and neck cancer will receive ADXS-HPV immunotherapy during the "window" of time between initial diagnosis and minimally invasive transoral robotic surgery to remove their tumors.

21 Jan 2014

Illumina inks multi-year supply agreement with LabCorp

Illumina, Inc. today announced it has entered into a multi-year supply agreement with Laboratory Corporation of America Holdings. The agreement gives LabCorp expanded rights to use Illumina next-generation sequencing and microarray equipment and supplies to develop, validate and introduce laboratory-developed tests to clinicians in the United States and Canada.

From Illumina, Inc. 21 Jan 2014

New Microlab® NIMBUS® Select workstation with Ranger Technology launched by Hamilton Robotics and Coastal Genomics

At the annual Society for Laboratory Automation and Screening (SLAS) meeting Hamilton Robotics has announced a partnership with Coastal Genomics to launch the new Microlab® NIMBUS® Select workstation with Ranger Technology. The new automated workstation provides a faster and more economical automated solution to agarose gel selection of DNA fragments, generating high-quality material for downstream use in next-generation sequencing (NGS), cloning and gene synthesis applications.

20 Jan 2014

Sapio Sciences announces release of Exemplar NGS LIMS system

Sapio Sciences is pleased to announce the release of Exemplar NGS LIMS. Sapio's NGS LIMS system will track multiple next-generation sequencing platform workflows from request through processing and analysis.

20 Jan 2014

Scientists develop new class of molecules that provide new way to attack bacteria resistant to antibiotics

As concerns about bacterial resistance to antibiotics grow, researchers are racing to find new kinds of drugs to replace ones that are no longer effective. One promising new class of molecules called acyldepsipeptides - ADEPs - kills bacteria in a way that no marketed antibacterial drug does - by altering the pathway through which cells rid themselves of harmful proteins.

20 Jan 2014

Next Generation News and Research

Claret receives CE Mark for Sentinel CPS for embolic protection during aortic valve replacement

New halal testing method for detecting pig and horse contamination of meat

GenePeeks receives patent for developing innovative algorithms to create hypothetical "digital babies"

Myelin Repair Foundation enters into agreement with NIH to assess MRF-008 for multiple sclerosis

DKFZ, AstraZeneca EORTC join Worldwide Innovative Network Consortium

UM professors receive grant to help athletes, military members suffering from traumatic brain injury

Collaboration between NFL and GE seeks to improve safety of athletes, soldiers who sustain mild TBI

Researchers use advanced neuroimaging techniques to study how concussions affect blood flow in brain

Next-generation high content screening system launched by PerkinElmer

Exposing adolescent to marijuana can lead to behavioral alterations in next generation

NCCC physicians use new gene sequencing equipment for testing abnormal DNA in cancerous tumor cells

Scientists develop new genetic platform that yields novel antibiotic from ocean bacteria

Vivaldi Biosciences inks agreement with NIAID to evaluate LAIV candidates against influenza A

Fluxion Biosciences announces release of IsoFlux Rare Cell Enrichment Kit

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Illumina inks multi-year supply agreement with LabCorp

New Microlab® NIMBUS® Select workstation with Ranger Technology launched by Hamilton Robotics and Coastal Genomics

Sapio Sciences announces release of Exemplar NGS LIMS system

Scientists develop new class of molecules that provide new way to attack bacteria resistant to antibiotics

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News